Live from the NIH registry
Studies recruiting near Davenport right now
Top 25 of 47 recruiting studies, sorted by proximity — each links to its official registry page
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
University of Iowa Health Care Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Revolution Medicines, Inc.
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: SWOG Cancer Research Network
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Amgen
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Heart Failure, Heart Failure NYHA Class II
N/A
Interventional 2,500 participants sought
Cardiovascular Medicine — Moline, Illinois (5.8 mi)
· Sponsor: CVRx, Inc.
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Davenport, Iowa (2.7 mi)
· Sponsor: DalCor Pharmaceuticals
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: NRG Oncology
FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW
Chronic Total Occlusion of Artery of the Extremities
N/A
Interventional 65 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Versono Medical Ltd
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2, Phase 3
Interventional 378 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: National Cancer Institute (NCI)
The THOR IDE Study
Peripheral Artery Disease, Peripheral Artery Stenosis
N/A
Interventional 155 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8
Phase 2
Interventional 146 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Arterial Disease of Legs, Below-the-knee Obstruction
N/A
Interventional 368 participants sought
Vascular Institute of the Midwest — Davenport, Iowa (2.7 mi)
· Sponsor: Concept Medical Inc.
EVERO Drug-coated Balloon (DCB) Randomized Trial
Peripheral Vascular Disease, Peripheral Arterial Disease
N/A
Interventional 410 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Cook Research Incorporated
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Chickenpox
Phase 3
Interventional 1,840 participants sought
GSK Investigational Site — Moline, Illinois (5.8 mi)
· Sponsor: GlaxoSmithKline
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
Hematopoietic and Lymphoid Cell Neoplasm, Immune System Disorder
N/A
Observational 2,240 participants sought
MercyOne Genesis Davenport Medical Center — Davenport, Iowa (2.7 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes
Peripheral Arterial Disease
N/A
Observational 14,000 participants sought
Mid West Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Baylor Research Institute
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Moline, Illinois (5.8 mi)
· Sponsor: AstraZeneca
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8
Phase 2
Interventional 94 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: SWOG Cancer Research Network
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Trinity Medical Center — Moline, Illinois (5.8 mi)
· Sponsor: SWOG Cancer Research Network
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa (5.1 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
AcoArt Litos PCB Below-the-knee Global Trial
Chronic Limb-Threatening Ischemia
N/A
Interventional 288 participants sought
Midwest Cardiovascular Research Foundation — Davenport, Iowa (2.7 mi)
· Sponsor: Acotec Scientific Co., Ltd